Ricerca Biosciences

• Preclinical Development: This likely encompasses services such as drug formulation development, pharmacokinetics (PK) and pharmacodynamics (PD) studies, toxicology studies, and analytical chemistry support for assay development and sample analysis. Their involvement in preclinical research would be crucial in evaluating the safety and efficacy of new drug candidates before they progress to human clinical trials.

• Bioanalytical Services: This involves developing and validating methods for measuring drug concentrations in biological samples (e.g., blood, plasma, tissue) to support pharmacokinetic and pharmacodynamic studies, as well as bioequivalence studies.

• Chemistry, Manufacturing, and Controls (CMC): This area likely encompasses support for the manufacturing process of drug substances and drug products, ensuring quality control and compliance with regulatory requirements.

Their services are likely geared towards helping pharmaceutical and biotechnology companies accelerate their drug development programs through efficient and high-quality research services, reducing their overall time-to-market for new drugs. Given their acquisition by Charles River Laboratories, it's likely that their operations are integrated with other Charles River services, providing clients with a comprehensive suite of drug development support. The specific locations of their facilities within the USA are not detailed on their limited website but are likely distributed strategically to support their client base and access talent pools. The scale of their operations likely indicates a significant contribution to the US biotech and life sciences landscape.